Back to Search
Start Over
A double‐blind, placebo‐controlled study of the effect of a TNFα inhibitor, Etanercept, on microglial activation in amyloid PET‐positive patients with mild cognitive impairment due to AD‐intermediate likelihood
- Source :
- Alzheimer's & Dementia. 16
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
- Subjects :
- medicine.medical_specialty
Epidemiology
business.industry
Health Policy
Placebo-controlled study
Amyloid pet
Inflammation
Gastroenterology
Etanercept
Double blind
Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Internal medicine
medicine
Tumor necrosis factor alpha
Neurology (clinical)
Geriatrics and Gerontology
medicine.symptom
Cognitive impairment
business
medicine.drug
Subjects
Details
- ISSN :
- 15525279 and 15525260
- Volume :
- 16
- Database :
- OpenAIRE
- Journal :
- Alzheimer's & Dementia
- Accession number :
- edsair.doi...........2ca85f25b2a884198d0a4c5e9849f7f7
- Full Text :
- https://doi.org/10.1002/alz.040331